Symptom Control and Impact on Daily Life in Patients With Gastroesophageal Reflux Disease

NCT01432392 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2012-05-10

No results posted yet for this study

Summary

The purpose of this study is to evaluate the impact of gastroesophageal reflux disease (GERD) treatment in primary care setting on symptom control and daily life in symptomatic GERD patients, using both GERD questionnaire and clinical symptoms assessment

Conditions

  • Gastroesophageal Reflux Disease

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2012-04-30
Completion
2012-04-30

Countries

  • Bulgaria

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01432392 on ClinicalTrials.gov